Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Volumes spurt at Concord Biotech Ltd counter
Concord Biotech Ltd notched up volume of 53.35 lakh shares by 14:14 IST on NSE, a 14.12 fold spurt over two-week average daily volume of 3.78 lakh shares
Volumes jump at Concord Biotech Ltd counter
Concord Biotech Ltd witnessed volume of 1.68 lakh shares by 10:46 IST on BSE, a 9.35 times surge over two-week average daily volume of 17948 shares
Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspension
Concord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the USFDA for its Mycophenolate Mofetil for Oral Suspension. This antimetabolite immunosuppressant is used in organ transplant patients.
Concord Biotech gains after receiving USFDA approval for Mycophenolate Mofetil
Concord Biotech jumped 3.81% to Rs 1210.60 after the company received an approval from the U.S. Food and Drug Administration (USFDA) for its ANDA, Mycophenolate Mofetil for oral suspension USP, 200 mg/mL.
Concord Biotech jumps 8% after USFDA approves Mycophenolate Mofetil ANDA
Concord Biotech received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL.
Concord Biotech gains 6% on USFDA nod for drug with $30 million US market opportunity
According to industry estimates cited by the company, the US market for Mycophenolate Mofetil is valued at approximately $30 million.
Stock Alert: APSEZ, Infosys, Dhanuka Agritech, Concord Biotech, Mufin Green Finance, Canara Bank
Adani Ports & Special Economic Zone (APSEZ) handled cargo volumes of 48.3 million metric tonnes (MMT) in May, marking a 16% year-on-year increase, driven by strong growth across key ports and cargo segments. However, the company's logistics business witnessed a decline, with rail volumes falling 19% year-on-year to 48,170 TEUs during the month.
Stocks to Watch for June 3: Canara Bank, Adani Ports, John Cockerill, Concord Biotech and more
Adani Ports cargo up 15%, rail volumes down 19 percent, Canara Bank to raise ₹8500 crore via bonds, Concord Biotech gets US FDA nod, Dhanuka Agritech starts buyback. Here are few stocks to track ahead of Wednesday trading session.
Concord Biotech receives USFDA approval for Mycophenolate Mofetil for Oral Suspension USP
Concord Biotech gets FDA nod for immunosuppressant mycophenolate mofetil
Mycophenolate mofetil is an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection in adult and paediatric recipients aged three months and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants. Shares of Concord Biotech Ltd ended at ₹1,166.80, up by ₹106.20, or 10.01%, on the BSE today, June 2.
Top Gainers & Losers on June 2: Newgen Software Tech, Concord Biotech, TCS, HFCL, NMDC among top gainers
On June 2, Indian stocks rebounded with benchmarks up over 0.5%, driven by technology shares. The Nifty 50 and Sensex closed at 23,506 and 74,692, respectively. However, India fell to seventh in global market capitalisation due to overseas selling and weak earnings growth.
Newgen Software Technologies Ltd leads gainers in 'A' group
Concord Biotech Ltd, ACME Solar Holdings Ltd, Sky Gold & Diamonds Ltd and Tata Consultancy Services Ltd are among the other gainers in the BSE's 'A' group today, 02 June 2026.